摘要
缺血再灌注损伤(IR I)是一种重要的病理生理现象。研究发现细胞因子在IR I发病机制中扮演重要角色。从目前的研究看,以细胞因子为治疗靶标防治IR I导致的器官损害是有前景的。
Ischemia-reperfusion injury (IRI) is an important phenomenon of patho-physiology. In the past years, researches found that the roles of cytokines are very important in ischemia and reperfusion. Cytokines and chemokine-targeted therapies to circumvent ischemia-reperfusion injury in organs hold promise for the future.
出处
《国际病理科学与临床杂志》
CAS
2006年第3期243-245,249,共4页
Journal of International Pathology and Clinical Medicine
基金
复旦大学"985工程"-肺损伤和炎症科技创新平台资助项目(复旦学科D-11)